Pantis Papaloizou, managing director of the family company CG Papaloisou Ltd, gives his insights on the healthcare changes that will happen in Cyprus and their impact for local importers of innovative medicines. He also highlights the key role of Papaloisou in the local market and how he plans to strengthen the company in the future.
Can you give us an overview of Papaloisou’s key activities?
"We are looking to attract new suppliers, placing emphasis on the high quality of the services we can provide. Indeed, we are inspected and audited very regularly by international partners and we perform well, offering stability and security. We are also efficient and competitive covering the entire island, both public and private sector."
